Skip to content

Observational Study on the Efficacy of Silver Needle Pre-Release Combined with Sedation and Analgesia in the Manipulative Release of adhesive capsulitis

Observational Study on the Efficacy of Silver Needle Pre-Release Combined with Sedation and Analgesia in the Manipulative Release of adhesive capsulitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000366
Enrollment
Unknown
Registered
2024-09-03
Start date
2024-07-15
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adhesive capsulitis

Interventions

control group:sedation and analgesia for manual release
Experimental group:Silver needle pre release combined with sedation and analgesia for manual release

Sponsors

Xiamen Medical University Affiliated Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age Range: Participants must be between 45 and 70 years of age. Duration of Symptoms: The duration of shoulder pain or stiffness must be more than 1 month. Absence of Severe Underlying Diseases: No history of severe cardiac disease. No history of neurological disorders. No history of coagulation dysfunction or other relevant hematological disorders. Voluntary Participation and Informed Consent: Participants must voluntarily agree to participate in the study and sign an informed consent form indicating their understanding of the study's objectives procedures potential risks and benefits.

Exclusion criteria

Exclusion criteria: (1) shoulder joint X-ray examination excludes patients with shoulder fractures and dislocations MRI examination excludes patients with rotator cuff injuries of grade three or above and excludes patients with tendon ruptures; (2) Patients who have received invasive treatment for other shoulder injuries within the past half month; (3) Shoulder pain caused by other reasons; (4) Patients with local skin infections in the treatment area as well as those with hematological and psychiatric disorders who cannot cooperate with treatment and have contraindications for invasive procedures

Design outcomes

Primary

MeasureTime frame
range of motion;NRS;

Secondary

MeasureTime frame
Medication;Sleep rating;

Countries

China

Contacts

Public ContactGuanghui Zhang

Xiamen Medical University Affiliated Second Hospital

372499021@qq.com+86 159 6003 6903

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026